AR012896A1 - Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori - Google Patents
Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pyloriInfo
- Publication number
- AR012896A1 AR012896A1 ARP980102558A ARP980102558A AR012896A1 AR 012896 A1 AR012896 A1 AR 012896A1 AR P980102558 A ARP980102558 A AR P980102558A AR P980102558 A ARP980102558 A AR P980102558A AR 012896 A1 AR012896 A1 AR 012896A1
- Authority
- AR
- Argentina
- Prior art keywords
- helicobacter pylori
- polypeptide
- compositions
- manufacture
- detection
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 206010019375 Helicobacter infections Diseases 0.000 title abstract 3
- 238000009007 Diagnostic Kit Methods 0.000 title abstract 2
- 241000590002 Helicobacter pylori Species 0.000 title abstract 2
- 238000001514 detection method Methods 0.000 title abstract 2
- 238000002405 diagnostic procedure Methods 0.000 title abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56922—Campylobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un polipéptido FlgE de Helicobacter pylori, o su forma modificada que retiene antigenicidad funcionalmente equivalente, para uso en la induccion deuna respuesta inmune protectora a la infeccion de Helicobacter pylori, composicion de vacuna, uso de dicho polipéptido para la fabricacion decomposiciones, método de diagnostico in vitro y kit de diagnostico para la deteccion de la infeccion por Helicobacter pylori.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9702242A SE9702242D0 (sv) | 1997-06-12 | 1997-06-12 | Vaccine compositions V |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR012896A1 true AR012896A1 (es) | 2000-11-22 |
Family
ID=20407351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980102558A AR012896A1 (es) | 1997-06-12 | 1998-06-01 | Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1009764A1 (es) |
| JP (1) | JP2002507118A (es) |
| KR (1) | KR20010013699A (es) |
| CN (1) | CN1259960A (es) |
| AR (1) | AR012896A1 (es) |
| AU (1) | AU8048798A (es) |
| BR (1) | BR9810026A (es) |
| CA (1) | CA2293293A1 (es) |
| EE (1) | EE9900566A (es) |
| HU (1) | HUP0003164A3 (es) |
| ID (1) | ID23052A (es) |
| IL (1) | IL133144A0 (es) |
| IS (1) | IS5288A (es) |
| NO (1) | NO996132L (es) |
| NZ (1) | NZ501427A (es) |
| PL (1) | PL337503A1 (es) |
| SE (1) | SE9702242D0 (es) |
| SK (1) | SK173099A3 (es) |
| TR (1) | TR199903060T2 (es) |
| WO (1) | WO1998056816A1 (es) |
| ZA (1) | ZA984696B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104784687A (zh) * | 2015-04-27 | 2015-07-22 | 苏州大学附属第一医院 | 重组绿脓杆菌鞭毛钩蛋白FlgE的用途 |
| CN113425717B (zh) * | 2021-04-22 | 2023-06-16 | 成都欧林生物科技股份有限公司 | 一种提高口服幽门螺杆菌疫苗效力的药剂及其应用 |
| CN116535472B (zh) * | 2023-05-31 | 2024-04-30 | 四川大学华西医院 | 一种幽门螺杆菌重组蛋白抗原FlgK及其制备方法与应用 |
| CN118105473B (zh) * | 2024-04-30 | 2024-08-16 | 成都欧林生物科技股份有限公司 | 一种预防或治疗Hp感染口服免疫原性组合物及其应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5459041A (en) * | 1988-02-18 | 1995-10-17 | Enteric Research Laboratories, Inc. | Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
| AR003125A1 (es) * | 1995-06-01 | 1998-07-08 | Astra Ab | Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la |
-
1997
- 1997-06-12 SE SE9702242A patent/SE9702242D0/xx unknown
-
1998
- 1998-06-01 AR ARP980102558A patent/AR012896A1/es unknown
- 1998-06-01 ZA ZA984696A patent/ZA984696B/xx unknown
- 1998-06-08 PL PL98337503A patent/PL337503A1/xx unknown
- 1998-06-08 NZ NZ501427A patent/NZ501427A/xx unknown
- 1998-06-08 SK SK1730-99A patent/SK173099A3/sk unknown
- 1998-06-08 EE EEP199900566A patent/EE9900566A/xx unknown
- 1998-06-08 KR KR1019997011714A patent/KR20010013699A/ko not_active Application Discontinuation
- 1998-06-08 JP JP50228399A patent/JP2002507118A/ja active Pending
- 1998-06-08 HU HU0003164A patent/HUP0003164A3/hu unknown
- 1998-06-08 CN CN98806101A patent/CN1259960A/zh active Pending
- 1998-06-08 CA CA002293293A patent/CA2293293A1/en not_active Abandoned
- 1998-06-08 EP EP98928772A patent/EP1009764A1/en not_active Withdrawn
- 1998-06-08 WO PCT/SE1998/001093 patent/WO1998056816A1/en not_active Application Discontinuation
- 1998-06-08 AU AU80487/98A patent/AU8048798A/en not_active Abandoned
- 1998-06-08 ID IDW991542A patent/ID23052A/id unknown
- 1998-06-08 BR BR9810026-2A patent/BR9810026A/pt not_active IP Right Cessation
- 1998-06-08 IL IL13314498A patent/IL133144A0/xx unknown
- 1998-06-08 TR TR1999/03060T patent/TR199903060T2/xx unknown
-
1999
- 1999-12-08 IS IS5288A patent/IS5288A/is unknown
- 1999-12-10 NO NO996132A patent/NO996132L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO996132L (no) | 2000-01-28 |
| CN1259960A (zh) | 2000-07-12 |
| CA2293293A1 (en) | 1998-12-17 |
| WO1998056816A1 (en) | 1998-12-17 |
| PL337503A1 (en) | 2000-08-28 |
| NZ501427A (en) | 2000-09-29 |
| EP1009764A1 (en) | 2000-06-21 |
| SK173099A3 (en) | 2000-06-12 |
| EE9900566A (xx) | 2000-06-15 |
| HUP0003164A2 (hu) | 2000-12-28 |
| TR199903060T2 (xx) | 2000-09-21 |
| SE9702242D0 (sv) | 1997-06-12 |
| ZA984696B (en) | 1999-01-04 |
| JP2002507118A (ja) | 2002-03-05 |
| NO996132D0 (no) | 1999-12-10 |
| IS5288A (is) | 1999-12-08 |
| KR20010013699A (ko) | 2001-02-26 |
| AU8048798A (en) | 1998-12-30 |
| ID23052A (id) | 2000-01-20 |
| IL133144A0 (en) | 2001-03-19 |
| HUP0003164A3 (en) | 2001-10-29 |
| BR9810026A (pt) | 2000-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200806258T2 (tr) | Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler | |
| CO5210894A1 (es) | Composiciones adyudantes que comprenden una sal de aluminio y un inmunoestimulante | |
| ES2062355T3 (es) | Composicion farmaceutica que comprende loratadina, ibuprofeno y pseudoefedrina. | |
| AR003006A1 (es) | Composición de vacuna combinada que comprende un polisacarido capsular de haemophilus influenzae b conjugado con una proteina portadora adsorbido sobre fosfato de aluminio y uno u otros antígenos distintos, métodos para producirla, y su uso para preparar un medicamento | |
| CO5700790A2 (es) | Composiciones de vacuna que comprenden una interleucina 18 y sistema de adyuvante de saponina | |
| NO991524L (no) | Vaksiner | |
| GB9626484D0 (en) | Helicobacter pylori antigenic protein preparation and immunoassays | |
| ATE329617T1 (de) | Antigen enthaltende zusammensetzung, die zusätzlich derivatisierte monoglyceride oder diglyceride als adjuvantien enthält | |
| MX9400166A (es) | Microesferas de proteina vegetal, hidrolizada, modificada y metodos para su preparacion y su uso. | |
| DK0528859T3 (da) | Oral vaccine, som omfatter antigen knyttet til overfladen af røde blodlegemer | |
| PT1171143E (pt) | Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto | |
| DE3852761D1 (de) | Saponin-hilfsmittel. | |
| NO976060L (no) | Vaksiner mot hepatitt C | |
| ATE223702T1 (de) | Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien | |
| ES2195169T3 (es) | Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion. | |
| MX24890A (es) | Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene. | |
| AR012896A1 (es) | Polipeptido flge de helicobacter pylori, composicion de vacuna, uso de dicho polipeptido para la fabricacion de composiciones, metodo de diagnostico invitro, y kit de diagnostico para la deteccion de la infeccion por helicobacter pylori | |
| DE60036692D1 (de) | Zusammensetzungen und methoden zur detektion einer trypanosoma cruzi infektion | |
| ES2079851T3 (es) | Uso de il-4 para mejorar la respuesta inmunitaria frente a inmunogenos en vacunas. | |
| DK0451688T3 (da) | Pulverformige dentalindstøbningsmasser med forbedrede strømningsegenskaber | |
| DE69637435D1 (de) | Saponin-zusammensetzungen und deren verwendung | |
| BR0013574A (pt) | Antìgeno vacina de moraxella | |
| ATE353226T1 (de) | Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form | |
| BR0115095A (pt) | Composição de vacina, e, método para induzir uma resposta imune em um ruminante para prover proteção imune que reduz a severidade de ou infecção por a. marginale | |
| IT8121484A0 (it) | Estratto da piante del genere epimedium, procedimento per lapreparazione di detto estratto, agente immunostimolante che comprende detto estratto come componente efficace e immunoterapia mediante l'impiego di detto estratto. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |